Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGAVE influenza vaccination antibody glycosylation study
2024-513981-21-00Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of live attenuated influenza vaccine and quadrivalent influenza vaccine in influenza (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Fold change in influenza-specific IgA in nasal fluid at day 21. Started Sep 2025; status: completed.
02
Drugs
live attenuated influenza vaccinequadrivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2024-513981-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513981-21-00.